GENX OTC
Genex Pharmaceutical, Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -0.0%
5Y: -99.0%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$3M
+32.8% ▲
4Y CAGR: +452.1%
Gross Profit
$3M
+29.4% ▲
Operating Income
$466K
-44.9% ▼
4Y CAGR: +72.8%
Net Income
$343K
-44.7% ▼
EPS (Diluted)
$0.02
-36.0% ▼
EBITDA
$790K
-12.5% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2003 | FY2004 | FY2005 | FY2006 | FY2007 |
|---|---|---|---|---|---|
| Revenue | $3K | $2M | $2M | $2M | $3M |
| YoY Growth | +0.0% | +67372.0% | +6.0% | -2.1% | +32.8% |
| Cost of Revenue | $4K | $283K | $302K | $217K | $363K |
| Gross Profit | -$301 | $2M | $2M | $2M | $3M |
| Gross Margin | -8.6% | 88.0% | 87.9% | 91.1% | 88.8% |
| R&D Expenses | $0 | $0 | $86K | $1K | $196K |
| SG&A Expenses | $162 | $1M | $1M | $1M | $2M |
| Operating Expenses | -$53K | $1M | $1M | $1M | $2M |
| Operating Income | $52K | $992K | $921K | $847K | $466K |
| Operating Margin | 1500.3% | 42.2% | 37.0% | 34.7% | 14.4% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | $0 | $1M | $953K | $1M | $734K |
| Tax Expense | $0 | $0 | $328K | $407K | $391K |
| Net Income | -$52K | $1M | $625K | $619K | $343K |
| Net Margin | -1500.3% | 43.1% | 25.1% | 25.4% | 10.6% |
| EPS (Diluted) | $-0.01 | $0.06 | $0.04 | $0.03 | $0.02 |
| EBITDA | -$49K | $1M | $980K | $903K | $790K |
| Shares Outstanding | 11M | 18M | 18M | 18M | 18M |